NASDAQFinancialsInsurance - LifeSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Achieve and maintain compliance with Nasdaq listing requirements | The company targets compliance with Nasdaq listing rules to avoid delisting risks. | Under Pressure | Receipt of new Nasdaq delisting notice or actual delisting | Delisting notice received vs no notice target Company received a Nasdaq Staff Delisting Determination on Oct 16, 2026, following prior non-compliance notices for late filings. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Maintain positive operating cash flow near $9.3M quarterly | Atlantic American aims to maintain positive operating cash flow near $9.3M quarterly. | Broken | operating cash flow falls below $9M in any quarter | Cash from operations: $17.676M FY2025-Q4; GAAP. Published target: >= $9.28M per quarter. Target period is not explicitly aligned with this observation. Source published Oct 16, 202617,676,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2025-Q4 · Period ending Dec 31, 2025 Source: stock_quarterly_financials_fmp. Reference: 2025-Q4. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve revenue growth near 8.5% next year | Analysts expect about 8.5% revenue growth next year. | Intact | YoY revenue growth falls below 6% in FY26 | Revenue growth: 4.53% FY2025-Q4; GAAP. Published target: >= 8% YoY revenue growth. Target period is not explicitly aligned with this observation. Source published Oct 16, 20264.530718 percent · calculatedSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2025-Q4 · Period ending Dec 31, 2025 Source: stock_quarterly_financials_fmp. Reference: 2025-Q4. Source status: unverified. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 13, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk turnaround case, not a proven compounder. The long-term thesis is in watch status because recent performance is weak and sits well below its industry cohort, while management execution remains volatile.
AAME screens cheap versus peers, but the expectations gap is negative, so the discount does not by itself signal that the market is overlooking strong prospects. The priced-in assessment is tagged justified, with low fragility, but valuation evidence is only medium confidence and recently fell by 15.5 points.
Near term, the business faces weak financial performance and a sector headwind, while management has made limited progress toward regaining Nasdaq filing compliance. One supplied quarter showed revenue and net income, but the reports were still delinquent in the August 2026 statement; sustained profitable growth and strong operating cash flow remain priorities to watch.
The multi-year thesis hinges on improved operating results and management restoring filing compliance. Near term, another guidance cut or a shift to lower interest rates would add pressure, while continued earnings strength and higher guidance from sector bellwethers could support sector momentum.
Over the next 1 to 3 years, AAME remains a fragile, high-risk turnaround thesis, with a peer discount set against weak fundamentals and unresolved compliance concerns. The evidence is medium confidence, and progress on reporting and sustained profitable growth is central to the case. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.